Craig Eagle has landed at Provectus
This article was originally published in Scrip
Executive Summary
Provectus Pharmaceuticals, a development-stage oncology and dermatology biopharmaceutical company, has appointed Dr Craig Eagle to its corporate advisory board. Dr Eagle is currently vice-president of strategic alliances and partnerships for the oncology unit at Pfizer, where he has served in various roles since 2001.